| scholarly article | Q13442814 |
| P50 | author | David C. Marsh | Q42393440 |
| P2093 | author name string | Zainab Samaan | |
| Dipika Desai | |||
| Monica Bawor | |||
| Chetna J Mistry | |||
| P2860 | cites work | Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction | Q24320057 |
| Dorsal anterior cingulate cortex: a role in reward-based decision making | Q24531372 | ||
| Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms | Q24535898 | ||
| Stress, dysregulation of drug reward pathways, and the transition to drug dependence | Q24629577 | ||
| Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability | Q24633664 | ||
| The neurobiology and genetics of impulse control disorders: relationships to drug addictions | Q24642641 | ||
| Regulations of opioid dependence by opioid receptor types | Q28214041 | ||
| Association of the kappa-opioid system with alcohol dependence | Q28259296 | ||
| Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1 | Q28262025 | ||
| Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction | Q28287764 | ||
| The neural basis of addiction: a pathology of motivation and choice | Q29615901 | ||
| Major increases in opioid analgesic abuse in the United States: concerns and strategies | Q30241262 | ||
| Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories | Q30482565 | ||
| A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling | Q31532158 | ||
| Risk factors for adolescent substance abuse and dependence: data from a national sample | Q31566599 | ||
| Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli | Q33767996 | ||
| BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization | Q33945215 | ||
| Molecular neurobiology of drug addiction | Q34292913 | ||
| Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking | Q34367845 | ||
| The Harvard Twin Study of Substance Abuse: what we have learned | Q34400983 | ||
| Musculoskeletal pain: prescription of NSAID and weak opioid by primary health care physicians in Sweden 2004-2008 - a retrospective patient record review | Q34418355 | ||
| Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool | Q34473918 | ||
| Genomewide suggestive linkage of opioid dependence to chromosome 14q. | Q34615928 | ||
| Opioid pharmacology | Q34774657 | ||
| Variation in NGFB is associated with primary affective disorders in women | Q35025772 | ||
| Nerve growth factor β polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment | Q35087543 | ||
| The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk | Q35184664 | ||
| Treating opioid dependence. Growing implications for primary care | Q35652569 | ||
| Associations among types of impulsivity, substance use problems and neurexin-3 polymorphisms | Q35661896 | ||
| Mu opioid receptor: a gateway to drug addiction | Q35803141 | ||
| Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement | Q35844174 | ||
| The role of endogenous opioids in the placebo effect in post-traumatic stress disorder | Q35986965 | ||
| Direct costs of opioid abuse in an insured population in the United States | Q36184100 | ||
| Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study). | Q36274331 | ||
| Illicit opioid use and its key characteristics: a select overview and evidence from a Canadian multisite cohort of illicit opioid users (OPICAN). | Q36628467 | ||
| Role of the brain-derived neurotrophic factor at glutamatergic synapses. | Q37024497 | ||
| Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment | Q37160674 | ||
| Women who abuse prescription opioids: findings from the Addiction Severity Index-Multimedia Version Connect prescription opioid database | Q37227555 | ||
| Addiction and dependence in DSM-V | Q37267779 | ||
| Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline | Q37383814 | ||
| The glutamate homeostasis hypothesis of addiction | Q37538517 | ||
| The neurobiology of addictive disorders | Q37616113 | ||
| Empirical view of opioid dependence | Q37690282 | ||
| Review of regulatory programs and new opioid technologies in chronic pain management: balancing the risk of medication abuse with medical need | Q37740108 | ||
| Pain mechanisms in patients with chronic pain | Q37987195 | ||
| Pain management in post-craniotomy patients: a survey of canadian neurosurgeons | Q39757683 | ||
| Polymorphisms of brain-derived neurotrophic factor associated with heroin dependence | Q39764792 | ||
| The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor | Q40079119 | ||
| The role of glutamate in physical dependence on opioids | Q41727846 | ||
| Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities | Q42686475 | ||
| Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum. | Q43016890 | ||
| Association of VNTR polymorphisms in the MAOA promoter and DRD4 exon 3 with heroin dependence in male Chinese addicts | Q43135397 | ||
| Changes in illicit opioid use across Canada | Q43204618 | ||
| Potential association of DRD2 and DAT1 genetic variation with heroin dependence | Q43296088 | ||
| Differential effects of the dopamine D2/D3 receptor antagonist sulpiride on self-administration of morphine into the ventral tegmental area or the nucleus accumbens | Q43914285 | ||
| Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study | Q44125214 | ||
| The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment | Q44333574 | ||
| Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction. | Q44334409 | ||
| A118g polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin | Q44337414 | ||
| BDNF variability in opioid addicts and response to methadone treatment: preliminary findings. | Q44337437 | ||
| Control of hormonal stress reactivity by the endogenous opioid system | Q44337859 | ||
| Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden | Q44344913 | ||
| Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects | Q44345793 | ||
| Association between a delta opioid receptor gene polymorphism and heroin dependence in man. | Q44346554 | ||
| Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction. | Q44347586 | ||
| Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. | Q44348080 | ||
| Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis | Q44349115 | ||
| Geographical variation in opioid prescribing and opioid-related mortality in Ontario. | Q44349386 | ||
| Prevention of prescription opioid abuse: the role of the dentist | Q44351414 | ||
| Human delta-opioid receptor gene and susceptibility to heroin and alcohol dependence | Q44352797 | ||
| Risk factors for adolescent substance abuse | Q44778418 | ||
| Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins | Q44869447 | ||
| Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. | Q44885119 | ||
| Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence | Q45055775 | ||
| Non-medical use of prescription opioids and public health in Canada: an urgent call for research and interventions development. | Q46479857 | ||
| Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males | Q46657920 | ||
| Association between brain-derived neurotrophic factor 196 G/A polymorphism and personality traits in healthy subjects | Q48112979 | ||
| Effects of the DRD4 genotype on neural networks associated with executive functions in children and adolescents | Q48462508 | ||
| Opioids excite dopamine neurons by hyperpolarization of local interneurons | Q48543154 | ||
| An adoption study of genetic and environmental factors in drug abuse. | Q52077065 | ||
| Growing-Up With a Substance-Dependent Parent: Development of Subjective Risk and Protective Factors | Q56522989 | ||
| Genetic and environmental influences on transitions in drug use | Q57400510 | ||
| Familial Transmission of Substance Use Disorders | Q58564475 | ||
| Genetic and environmental influences on posttraumatic stress disorder, alcohol and drug dependence in twin pairs | Q73154630 | ||
| Association analysis of the dopamine D4 gene exon III VNTR and heroin abuse in Chinese subjects | Q73759594 | ||
| A two-year study of patterns and predictors of substance use among Mexican American youth | Q77098870 | ||
| Dopamine receptors, motor responses, and dopaminergic agonists | Q82297630 | ||
| P433 | issue | 2 | |
| P921 | main subject | opioid | Q427523 |
| P304 | page(s) | 156-167 | |
| P577 | publication date | 2014-05-01 | |
| P1433 | published in | Current Psychiatry Reviews | Q15749266 |
| P1476 | title | Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence | |
| P478 | volume | 10 |
| Q36424264 | Adding Genetic Testing to Evidence-Based Guidelines to Determine the Safest and Most Effective Chronic Pain Treatment for Injured Workers |
| Q41239687 | Analysis of morphine responses in mice reveals a QTL on Chromosome 7. |
| Q39532562 | Association Between Initial Opioid Prescribing Patterns and Subsequent Long-Term Use Among Opioid-Naïve Patients: A Statewide Retrospective Cohort Study |
| Q91959108 | Association Between Long-term Opioid Use in Family Members and Persistent Opioid Use After Surgery Among Adolescents and Young Adults |
| Q44346659 | Association of OPRD1 Gene Variants with Opioid Dependence in Addicted Male Individuals Undergoing Methadone Treatment in the North of Iran |
| Q93097750 | Characterization of DSM-IV Opioid Dependence Among Individuals of European Ancestry |
| Q59795503 | Drug Addiction: From Neuroscience to Ethics |
| Q91775826 | Four single nucleotide polymorphisms in genes involved in neuronal signaling are associated with Opioid Use Disorder in West Virginia |
| Q90648970 | GABRA2 rs279858-linked variants are associated with disrupted structural connectome of reward circuits in heroin abusers |
| Q92635298 | Genome-Wide Association Study of Opioid Cessation |
| Q52686362 | Genome-wide Association Study Identifies a Regulatory Variant of RGMA Associated With Opioid Dependence in European Americans. |
| Q91619689 | Genomewide Gene-by-Sex Interaction Scans Identify ADGRV1 for Sex Differences in Opioid Dependent African Americans |
| Q90394948 | Implication of OPRM1 A118G Polymorphism in Opioids Addicts in Pakistan: In vitro and In silico Analysis |
| Q91829800 | OPRM1 A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches |
| Q57462900 | Opioid Dependence Risk Factors and Risk Assessment |
| Q96134915 | Opioid-induced Somatic Activation: Prevalence in a Population of Patients With Chronic Pain |
| Q92356616 | Pattern and probability of dispensing of prescription opioids and benzodiazepines among the new users in Australia: a retrospective cohort study |
| Q89905655 | Pharmacotherapeutic management of co-morbid alcohol and opioid use |
| Q92461072 | Racial association and pharmacotherapy in neonatal opioid withdrawal syndrome |
| Q36470070 | Replication of ZNF804A gene variant associations with risk of heroin addiction |
| Q26740264 | Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk |
Search more.